Evidence map›Paper›PMID 36518610›Full record

ArticleRestorative dentistry & endodontics2022

Calcium-doped zinc oxide nanocrystals as an innovative intracanal medicament: a pilot study.

Gabriela Leite de Souza, Thamara Eduarda Alves Magalhães, Gabrielle Alves Nunes Freitas, Nelly Xiomara Alvarado Lemus, Gabriella Lopes de Rezende Barbosa, Anielle Christine Almeida Silva, Camilla Christian Gomes Moura

Abstract read
In one paragraph

Article in Restorative dentistry & endodontics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriela Leite de SouzaDepartment of Endodontics, School of Dentistry, Federal University of Uberlândia, Uberlândia, MG, Brazil.ORCID https://orcid.org/0000-0003-3505-5258
Thamara Eduarda Alves MagalhãesSchool of Dentistry, Federal University of Uberlândia, Uberlândia, MG, Brazil.ORCID https://orcid.org/0000-0001-5992-5073
Gabrielle Alves Nunes FreitasSchool of Dentistry, Federal University of Uberlândia, Uberlândia, MG, Brazil.ORCID https://orcid.org/0000-0001-7865-2795
Nelly Xiomara Alvarado LemusDepartment of Endodontics, School of Dentistry, Federal University of Uberlândia, Uberlândia, MG, Brazil.ORCID https://orcid.org/0000-0002-9658-2433
Gabriella Lopes de Rezende BarbosaDepartment of Oral Diagnosis, School of Dentistry, Federal University of Uberlândia, Uberlândia, MG, Brazil.ORCID https://orcid.org/0000-0002-5305-7671
Anielle Christine Almeida SilvaFunctional and New Nanostructured Materials Laboratory, Physics Institute, Federal University of Alagoas, Maceió, AL, Brazil.ORCID https://orcid.org/0000-0003-1959-2870
Camilla Christian Gomes MouraDepartment of Endodontics, School of Dentistry, Federal University of Uberlândia, Uberlândia, MG, Brazil.ORCID https://orcid.org/0000-0002-5653-8403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study investigated the cytotoxicity, radiopacity, pH, and dentinal tubule penetration of a paste of 1.0% calcium-doped zinc oxide nanocrystals (ZnO:1.0Ca) combined with propylene glycol (PRG) or polyethylene glycol and propylene glycol (PEG-PRG). Materials and Methods: The pastes were prepared by mixing calcium hydroxide [Ca(OH) Results: ZnO:1.0Ca materials showed lower viability at 1:1 and 1:2 dilutions than Ca(OH) Conclusions: ZnO:1.0Ca medicaments presented higher penetrability, cell viability, and radiopacity than Ca(OH)

Indexed as

Calcium hydroxideCell survivalNanoparticlesPhysicochemical propertiesZinc oxide

Identifiers

PMID36518610
PMCPMC9715372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.